Abstract
To address drug resistance caused by ALK kinase mutations, a series of novel 2,4-diarylaminopyrimidine (DAAP) analogues were designed by incorporating......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
